Caricamento...
NCMP-28. BEVACIZUMAB ASSOCIATED INTRACEREBRAL HEMORRHAGE IN PATIENTS WITH PRIMARY CNS MALIGNANCY
The risk of intracranial hemorrhage (ICH) associated with the use of bevacizumab (BEV) has been a topic of several reviews in the literature, and is considered to be a potential adverse effect of BEV when used in patients with malignant glioma. We performed a single-center retrospective chart-review...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650890/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.539 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|